Literature DB >> 5415678

The gastrointestinal stimulus to insulin release. II. A dual action of secretin.

E W Kraegen, D J Chisholm, J D Young, L Lazarus.   

Abstract

The insulin release after an oral glucose load is both earlier and greater than would be expected from the glycemic stimulus. This augmentation of insulin release has been attributed to humoral factors from the gut. It has been previously demonstrated that secretin is released very rapidly after oral glucose and postulated that it acts as an early trigger to insulin release. This effect would not explain the magnitude of the peak insulin response which occurs about 30 min after peak secretin levels. The present studies, however, demonstrate an additional action of secretin which may explain this. To further study the role of secretin in insulin release in normal subjects, two consecutive 20 min intravenous glucose infusions were administered 150 min apart with and without an intervening secretin infusion (10 U) given to approximate serum secretin levels seen after oral glucose ingestion. A highly significant (P<0.01) potentiation of the insulin response to the post-secretin glucose infusion was observed. This occurred both when secretin was given 7 min or 25 min before glucose. In the latter case, serum secretin was undetectable during the glucose infusion. These studies demonstrate that secretin potentiates the glycemic release of insulin. Despite the augmented insulin response, no consistent change in blood glucose variation was observed. This is consistent with the suggestion that the facilitated disposal of an alimentary glucose load is not dependent solely on enhanced insulin secretion. Secretin appears to have a dual role in insulin release, an early direct stimulation followed by a prolonged potentiation of the glycemic stimulus. The potentiating effect is of such magnitude to suggest that secretin is the dominant factor in the enteric component of insulin release after an oral glucose load.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5415678      PMCID: PMC322500          DOI: 10.1172/JCI106262

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Effects of secretin on insulin and glucagon in portal and peripheral blood in man.

Authors:  J Dupré; L Rojas; J J White; R H Unger; J C Beck
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

2.  Secretin and pancreozymin-cholecystokinin after glucose.

Authors:  J D Young; L Lazarus; D J Chisholm
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

Review 3.  Entero-insular axis.

Authors:  R H Unger; A M Eisentraut
Journal:  Arch Intern Med       Date:  1969-03

Review 4.  Role of insulin in the hepatic handling of glucose.

Authors:  L L Madison
Journal:  Arch Intern Med       Date:  1969-03

5.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration.

Authors:  A M Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

7.  Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin.

Authors:  D F Steiner; O Hallund; A Rubenstein; S Cho; C Bayliss
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461

8.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.

Authors:  J Dupre; J D Curtis; R H Unger; R W Waddell; J C Beck
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  17 in total

1.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

3.  Effect of massive bowel resection on enteroinsular axis.

Authors:  T Kajawara; T Szuki; T Tobe
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

Review 4.  Hormonal control of pancreatic endocrine and exocrine secretion.

Authors:  G Youngs
Journal:  Gut       Date:  1972-02       Impact factor: 23.059

5.  Studies of secretin-stimulated insulin responses in man.

Authors:  R L Lerner; D Porte
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

6.  Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection.

Authors:  S Wapnick; J J Jones
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

7.  The effect of gastrin on basal- and glucose-stimulated insulin secretion in man.

Authors:  J F Rehfeld; F Stadil
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

8.  The mechanism of insulin secretion after oral glucose administration. I. Multiphasic course of insulin mobilization after oral administration of glucose in conscious dogs. Differences to the behaviour after intravenous administration.

Authors:  U Fischer; H Hommel; M Ziegler; R Michael
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

Review 9.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

10.  Suppressive effect of secretin upon pancreatic alpha cell function.

Authors:  F Santeusanio; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.